AMAM logo

Ambrx Biopharma (AMAM) Selling, General & Administrative Expenses

Annual SGA

$20.84 M
+$3.77 M+22.05%

December 31, 2022

Summary

Performance

1-Year Change

+22.05%

3-Year Change

+225.56%

5-Year Change

+225.56%

15-Year Change

+225.56%

AMAM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$20.84 M
AMAM annual SGA is currently at an all-time high

3-Year Low

$17.07 M
AMAM annual SGA is currently +22.05% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
AMAM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
AMAM next annual earnings announcement has not yet been scheduled

OtherAMAMexpensesmetrics:

Annual Total Expenses

$74.14 M
AMAM annual total expenses is $74.14 million

Annual Operating Expenses

$74.14 M
AMAM annual total operating expenses is $74.14 million

Annual Cost Of Goods Sold

-
AMAM annual cost of goods sold value is unknown

Annual Interest Expense

$968.00 K
AMAM annual interest expense is $968.00 thousand

Quarterly SGA

$9.41 M
+$3.51 M+59.49%

September 1, 2023

Summary

Performance

3-Month Change

+59.49%

1-Year Change

+84.69%

3-Year Change

-

5-Year Change

-

AMAM Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.41 M
AMAM quarterly SGA is currently at an all-time high

3-Year Low

$4.57 M
AMAM quarterly SGA is currently +105.91% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
AMAM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
AMAM next earnings announcement has not yet been scheduled

OtherAMAMexpensesmetrics:

Quarterly Total Expenses

$25.68 M
AMAM quarterly total expenses is $25.68 million

Quarterly Operating Expenses

$25.68 M
AMAM quarterly total operating expenses is $25.68 million

Quarterly Cost Of Goods Sold

-
AMAM quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
AMAM quarterly interest expense value is unknown

TTM SGA

-$1.27 B
-$347.75 M-37.66%

September 1, 2023

Summary

Performance

3-Month Change

-5474.68%

1-Year Change

-8873.18%

3-Year Change

-

5-Year Change

-

AMAM TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$145.55 M

3-Year Low

-$1.27 B
AMAM TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
AMAM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
AMAM next earnings announcement has not yet been scheduled

OtherAMAMexpensesmetrics:

Annual Total Expenses

$74.14 M
AMAM annual total expenses is $74.14 million

Annual Operating Expenses

$74.14 M
AMAM annual total operating expenses is $74.14 million

TTM Cost Of Goods Sold

-
AMAM TTM cost of goods sold value is unknown

TTM Interest Expense

-
AMAM TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$20.84 M
AMAM annual SGA is $20.84 million

Annual Operating Expenses

$74.14 M
AMAM annual total operating expenses is $74.14 million

Annual Cost Of Goods Sold

-
AMAM annual cost of goods sold value is unknown

AMAM Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.1%+84.7%-8873.2%
3 y3 years+225.6%--
5 y5 years+225.6%--

AMAM Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-18.1%at high-51.4%+227.4%at low
5 y5-yearat high-69.5%at high-51.4%+773.3%at low
alltimeall timeat high-69.5%at high-51.4%+773.3%at low

Ambrx Biopharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2023
-
$9.41 M(+59.5%)
$27.96 M(+18.2%)
Jun 2023
-
$5.90 M(-6.4%)
$23.65 M(+4.8%)
Mar 2023
-
$6.31 M(-0.7%)
$22.57 M(+8.3%)
Dec 2022
$20.84 M
$6.35 M(+24.6%)
$20.84 M(+43.8%)
Sep 2022
-
$5.09 M(+5.6%)
$14.49 M(+54.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
$4.82 M(+5.5%)
$9.39 M(+105.5%)
Mar 2022
-
$4.57 M
$4.57 M
Dec 2021
$17.07 M(+168.7%)
-
-
Dec 2020
$6.35 M(-0.7%)
-
-
Dec 2019
$6.40 M
-
-

FAQ

  • What is Ambrx Biopharma annual SGA?
  • What is the all time high annual SGA for Ambrx Biopharma?
  • What is Ambrx Biopharma annual SGA year-on-year change?
  • What is Ambrx Biopharma quarterly SGA?
  • What is the all time high quarterly SGA for Ambrx Biopharma?
  • What is Ambrx Biopharma quarterly SGA year-on-year change?
  • What is Ambrx Biopharma TTM SGA?
  • What is the all time high TTM SGA for Ambrx Biopharma?
  • What is Ambrx Biopharma TTM SGA year-on-year change?

What is Ambrx Biopharma annual SGA?

The current annual SGA of AMAM is $20.84 M

What is the all time high annual SGA for Ambrx Biopharma?

Ambrx Biopharma all-time high annual SGA is $20.84 M

What is Ambrx Biopharma annual SGA year-on-year change?

Over the past year, AMAM annual SGA has changed by +$3.77 M (+22.05%)

What is Ambrx Biopharma quarterly SGA?

The current quarterly SGA of AMAM is $9.41 M

What is the all time high quarterly SGA for Ambrx Biopharma?

Ambrx Biopharma all-time high quarterly SGA is $9.41 M

What is Ambrx Biopharma quarterly SGA year-on-year change?

Over the past year, AMAM quarterly SGA has changed by +$4.32 M (+84.69%)

What is Ambrx Biopharma TTM SGA?

The current TTM SGA of AMAM is -$1.27 B

What is the all time high TTM SGA for Ambrx Biopharma?

Ambrx Biopharma all-time high TTM SGA is -$145.55 M

What is Ambrx Biopharma TTM SGA year-on-year change?

Over the past year, AMAM TTM SGA has changed by -$1.29 B (-8873.18%)